MiR-99a may serve as a potential oncogene in pediatric myeloid leukemia

MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6

(2013) Yuan Shao et al.   Cancer Cell International

How to treat CML patients in the tyrosine kinase inhibitors era? From imatinib standard dose to second generation drugs front-line: Unmet needs, pitfalls and advantages

(2012) Massimo Breccia et al.   CANCER LETTERS

MicroRNAs in B cell development and malignancy

(2012) Thilini R Fernando et al.   Journal of Hematology & Oncology

MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation status

(2012) Isabella Faraoni et al.   Journal of Hematology & Oncology

The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer

(2012) Catherine Labbaye et al.   Journal of Hematology & Oncology

MicroRNAs and Toll-like Receptor/Interleukin-1 Receptor Signaling

(2012) Anthony Virtue et al.   Journal of Hematology & Oncology

A miRNA expression signature that separates between normal and malignant prostate tissues

(2011) Jessica Carlsson et al.   Cancer Cell International

Activation of Paired-homeobox gene PITX1 by del(5)(q31) in T-cell acute lymphoblastic leukemia

(2011) Stefan Nagel et al.   LEUKEMIA & LYMPHOMA

MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia

(2011) Y-S Zheng et al.   ONCOGENE

Transformation by Tribbles homolog 2 (Trib2) requires both the Trib2 kinase domain and COP1 binding

(2010) K. Keeshan et al.   BLOOD

BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

(2010) S. Schwind et al.   BLOOD

Frequent alterations of the candidate genes hMLH1, ITGA9 and RBSP3 in early dysplastic lesions of head and neck: Clinical and prognostic significance

(2010) Amlan Ghosh et al.   CANCER SCIENCE

microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia

(2010) Yoon-Chi Han et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Tribbles-1 and -2 are tumour suppressors, down-regulated in human acute myeloid leukaemia

(2009) Daniel C. Gilby et al.   IMMUNOLOGY LETTERS

High Mutability of the Tumor Suppressor Genes RASSF1 and RBSP3 (CTDSPL) in Cancer

(2009) Vladimir I. Kashuba et al.   PLoS One

MicroRNA Patterns Associated with Clinical Prognostic Parameters and CNS Relapse Prediction in Pediatric Acute Leukemia

(2009) Hua Zhang et al.   PLoS One

MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia

(2008) R. Garzon et al.   BLOOD

Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue

(2008) T.-S. Wong et al.   CLINICAL CANCER RESEARCH

Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at 21q11-21 in human lung cancer

(2008) Hideki Yamada et al.   GENES CHROMOSOMES & CANCER

A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation

(2008) Zuoren Yu et al.   JOURNAL OF CELL BIOLOGY

Tribbles homolog 2 (Trib2) and HoxA9 cooperate to accelerate acute myelogenous leukemia

(2007) Karen Keeshan et al.   BLOOD CELLS MOLECULES AND DISEASES

Significance of age in acute myeloid leukemia patients younger than 30 years

(2007) Ursula Creutzig et al.   CANCER